SC 13G: Taysha Gene Therapies, Inc.
Ticker: TSHA · Form: SC 13G · Filed: Nov 8, 2024 · CIK: 1806310
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Taysha Gene Therapies, Inc..
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on November 8, 2024 regarding Taysha Gene Therapies, Inc. (TSHA).